# Tangji EU Gastric Bypass Stent Study for Obesity

> **NCT05249608** · NA · UNKNOWN · sponsor: **Hangzhou Tangji Medical Technology Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DEVICE:** A prospective, open-label, multicenter, single-arm clinical study to evaluate the safety and performance of the Gastric Bypass Stent System as a weight loss treatment for obesity

## Key facts

- **NCT ID:** NCT05249608
- **Lead sponsor:** Hangzhou Tangji Medical Technology Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-01
- **Primary completion:** 2025-02-02
- **Final completion:** 2025-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05249608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05249608, "Tangji EU Gastric Bypass Stent Study for Obesity". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05249608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*